USC professors recieve NIH funding for clinical trial of Alzheimer’s drug

By Kukla Vera

USC Professors Roberta Diaz Brinton, PhD, of the USC School of Pharmacy and Lon Schneider, MD, MS, of the Keck School of Medicine of USC are principal investigators of a newly funded study from the National Institutes of Health, aimed at testing promising drugs for the prevention of Alzheimer’s disease.

The USC project, “Allopregnanolone Regenerative Therapeutic for MCI/Alzheimer’s: Dose Finding Phase 1,” is the first clinical trial to evaluate the safety and tolerability of using allopregnanolone (Allo), a natural brain steroid, in treating mild cognitive impairment and Alzheimer’s disease, as part of an intensified national effort to find effective interventions for the degenerative brain disease. … Read More »

October 2nd, 2013|Announcements|

Ajay Vyas promoted to deputy health-care compliance officer

By Tania Chatila

Ajay Vyas, JD, has been promoted to deputy health-care compliance officer, effective Sept. 3. In his new role, Vyas is responsible for the day-to-day management and oversight of the compliance programs for Keck Hospital of USC, USC Norris Cancer Hospital, USC Verdugo Hills Hospital and the Keck Medical Center of USC.

He is also the compliance plan provider for USC Care Medical Group, the Ostrow School of Dentistry of USC, USC Division of Occupational Science and Occupational Therapy, USC Division of Biokinesiology and Physical Therapy and the USC School of Pharmacy.  … Read More »

October 2nd, 2013|Announcements|